Loading insider details...
Beta
Latest Form 4 (Oct 8, 2026): Grant/Award of 10,700 WVE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2026 | Wave Life Sciences, Inc. (WVE) | Grant/Award | 10,700 | n/a |
| Aug 14, 2026 | Wave Life Sciences, Inc. (WVE) | Sale | 12,700 | $67.2K |
| Dec 10, 2025 | Wave Life Sciences Ltd. (WVE) | Exercise/Conversion | 42,000 | $250.7K |
| Nov 14, 2025 | Wave Life Sciences Ltd. (WVE) | Sale | 16,115 | $109.4K |
| Aug 13, 2025 | Wave Life Sciences Ltd. (WVE) | Grant/Award | 12,700 | n/a |
| Feb 20, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 5,143,248 | n/a |
| Jan 18, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 30,601 | $17.8K |
| Jan 15, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 12,539 | $7.4K |
| Aug 14, 2024 | Wave Life Sciences Ltd. (WVE) | Grant/Award | 16,115 | n/a |
| Jan 17, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 9,304 | $7.4K |